Home > Boards > US Listed > Medical - Drugs > Dr. Reddy's Laboratories Limited (RDY)

Breaking News: $RDY Dr. Reddy's Laboratories Announces the

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
whytestocks Member Profile
 
Followed By 110
Posts 14,838
Boards Moderated 4
Alias Born 06/04/18
160x600 placeholder
Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India Business Wire - 1/15/2021 12:33:00 PM
Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India Business Wire - 1/11/2021 10:25:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/11/2021 8:48:27 AM
Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market Business Wire - 1/11/2021 4:59:00 AM
Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 Business Wire - 1/8/2021 8:21:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/29/2020 1:01:31 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/22/2020 7:36:44 AM
Dr. Reddy's Laboratories, Global Response Aid, & Appili Therapeutics Announce the Filing of an Application for REEQONUS™ (f... Business Wire - 12/22/2020 1:11:00 AM
Secondary Listing of Dr. Reddy’s ADRs on NSE IFSC Limited (GIFT City, Gujarat, India) Business Wire - 12/9/2020 4:20:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/8/2020 10:09:37 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/8/2020 9:53:55 AM
Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India Business Wire - 12/1/2020 8:15:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/30/2020 7:12:13 AM
Dr. Reddy’s to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan Business Wire - 11/28/2020 11:33:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/19/2020 10:04:04 AM
Dr. Reddy's Laboratories Announces the Launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) in the U.S. ... Business Wire - 11/12/2020 10:47:00 AM
Dr. Reddy’s Laboratories Presents Preclinical Data at SITC 2020 Demonstrating Significant Improvement in Tumor Growth Inhib... Business Wire - 11/9/2020 9:14:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/30/2020 8:21:20 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/29/2020 8:49:38 AM
Dr. Reddy's partners with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vacc... Business Wire - 10/29/2020 2:19:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/28/2020 12:36:41 PM
Dr. Reddy's Laboratories Announces Appointment of New Chief Financial Officer Business Wire - 10/28/2020 6:09:00 AM
Dr. Reddy’s Q2 & H1 FY21 Financial Results Business Wire - 10/28/2020 5:40:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/22/2020 9:58:28 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/20/2020 2:55:44 PM
whytestocks   Saturday, 09/26/20 07:15:26 AM
Re: None
Post # of 19 
Breaking News: $RDY Dr. Reddy's Laboratories Announces the Launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr.Reddy’s”) today announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfid...

In case you are interested RDY - Dr. Reddy's Laboratories Announces the Launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences